Hydrogen Sulfide, an Endogenous Stimulator of Mitochondrial Function in Cancer Cells
- PMID: 33499368
- PMCID: PMC7911547
- DOI: 10.3390/cells10020220
Hydrogen Sulfide, an Endogenous Stimulator of Mitochondrial Function in Cancer Cells
Abstract
Hydrogen sulfide (H2S) has a long history as toxic gas and environmental hazard; inhibition of cytochrome c oxidase (mitochondrial Complex IV) is viewed as a primary mode of its cytotoxic action. However, studies conducted over the last two decades unveiled multiple biological regulatory roles of H2S as an endogenously produced mammalian gaseous transmitter. Cystathionine -lyase (CSE), cystathionine β-synthase (CBS) and 3-mercaptopyruvate sulfurtransferase (3-MST) are currently viewed as the principal mammalian H2S-generating enzymes. In contrast to its inhibitory (toxicological) mitochondrial effects, at lower (physiological) concentrations, H2S serves as a stimulator of electron transport in mammalian mitochondria, by acting as an electron donor-with sulfide:quinone oxidoreductase (SQR) being the immediate electron acceptor. The mitochondrial roles of H2S are significant in various cancer cells, many of which exhibit high expression and partial mitochondrial localization of various H2S producing enzymes. In addition to the stimulation of mitochondrial ATP production, the roles of endogenous H2S in cancer cells include the maintenance of mitochondrial organization (protection against mitochondrial fission) and the maintenance of mitochondrial DNA repair (via the stimulation of the assembly of mitochondrial DNA repair complexes). The current article overviews the state-of-the-art knowledge regarding the mitochondrial functions of endogenously produced H2S in cancer cells.
Keywords: ATP; DNA repair; bioenergetics; gasotransmitters.
Conflict of interest statement
The author declares no conflict of interest.
Figures


Similar articles
-
Regulation of mitochondrial bioenergetic function by hydrogen sulfide. Part I. Biochemical and physiological mechanisms.Br J Pharmacol. 2014 Apr;171(8):2099-122. doi: 10.1111/bph.12369. Br J Pharmacol. 2014. PMID: 23991830 Free PMC article. Review.
-
Potential role of the 3-mercaptopyruvate sulfurtransferase (3-MST)-hydrogen sulfide (H2S) pathway in cancer cells.Pharmacol Res. 2020 Apr;154:104083. doi: 10.1016/j.phrs.2018.11.034. Epub 2018 Nov 27. Pharmacol Res. 2020. PMID: 30500457 Review.
-
Emerging roles of hydrogen sulfide-metabolizing enzymes in cancer.Redox Rep. 2024 Dec;29(1):2437338. doi: 10.1080/13510002.2024.2437338. Epub 2024 Dec 6. Redox Rep. 2024. PMID: 39643979 Free PMC article. Review.
-
Inhibition of hydrogen sulfide biosynthesis sensitizes lung adenocarcinoma to chemotherapeutic drugs by inhibiting mitochondrial DNA repair and suppressing cellular bioenergetics.Sci Rep. 2016 Nov 3;6:36125. doi: 10.1038/srep36125. Sci Rep. 2016. PMID: 27808278 Free PMC article.
-
Pharmacological induction of mesenchymal-epithelial transition via inhibition of H2S biosynthesis and consequent suppression of ACLY activity in colon cancer cells.Pharmacol Res. 2021 Mar;165:105393. doi: 10.1016/j.phrs.2020.105393. Epub 2021 Jan 20. Pharmacol Res. 2021. PMID: 33484818
Cited by
-
Oxidative Cysteine Post Translational Modifications Drive the Redox Code Underlying Neurodegeneration and Amyotrophic Lateral Sclerosis.Antioxidants (Basel). 2024 Jul 23;13(8):883. doi: 10.3390/antiox13080883. Antioxidants (Basel). 2024. PMID: 39199129 Free PMC article. Review.
-
Pharmacological Inhibition of Endogenous Hydrogen Sulfide Attenuates Breast Cancer Progression.Molecules. 2022 Jun 23;27(13):4049. doi: 10.3390/molecules27134049. Molecules. 2022. PMID: 35807290 Free PMC article.
-
Role of Cystathionine β-Synthase and 3-Mercaptopyruvate Sulfurtransferase in the Regulation of Proliferation, Migration, and Bioenergetics of Murine Breast Cancer Cells.Antioxidants (Basel). 2023 Mar 5;12(3):647. doi: 10.3390/antiox12030647. Antioxidants (Basel). 2023. PMID: 36978895 Free PMC article.
-
Potential therapeutic applications of medical gases in cancer treatment.Med Gas Res. 2025 Jun 1;15(2):309-317. doi: 10.4103/mgr.MEDGASRES-D-24-00089. Epub 2025 Jan 18. Med Gas Res. 2025. PMID: 39829166 Free PMC article. Review.
-
Analysis of hydrogen sulfide-related signatures of breast cancer identified 2 distinct subtypes: Implications for individualized therapeutics.Medicine (Baltimore). 2025 Apr 4;104(14):e42076. doi: 10.1097/MD.0000000000042076. Medicine (Baltimore). 2025. PMID: 40193637 Free PMC article.
References
-
- IRIS . Support of Summary Information on the Integrated Risk Information System. U.S. Environmental Protection Agency; Washington, DC, USA: 2003. Toxicological Review of Hydrogen Sulfide. CAS No. 7783-06-4.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical